Literature DB >> 23618586

Long-term structural and functional effects of autologous muscle precursor cell therapy in a nonhuman primate model of urinary sphincter deficiency.

Sherif Badra1, Karl-Erik Andersson, Ashley Dean, Sherif Mourad, J Koudy Williams.   

Abstract

PURPOSE: We measured the long-term efficacy of autologous muscle precursor cell therapy in premenopausal female nonhuman primates with sustained urinary sphincter deficiency.
MATERIALS AND METHODS: Urinary sphincter deficiency was created in adult premenopausal female cynomolgus monkeys by selectively cauterizing and then transecting the pudendal innervation to the sphincter complex. The monkeys were then treated (18) or not treated (18) with intra-urinary sphincter injections of 5 million autologous green fluorescent protein labeled skeletal muscle precursor cells. Four untreated, uninjured monkeys served as controls. Maximal urethral pressure measurement and corresponding histological analysis of the structural and cellular components of the sphincter complex were performed up to 12 months after injection.
RESULTS: Cell treatment produced sustained (12 months) increases in resting, somatic nerve stimulated and adrenergic nerve stimulated maximal urethral pressure, and a greater percent of sphincter area occupied by muscle as well as a decrease in the sphincter area occupied by collagen compared to the untreated group (each p>0.05). These results were within control values (each p>0.05). By 3 months after injection green fluorescent protein positive cells were found in the skeletal muscle layer, expressing desmin and connexin-43, and in the smooth muscle layer, expressing α-smooth muscle actin and connexin-43, and they were incorporated into the subendothelial vasculature, expressing Von Willebrand factor. Cell injected sphincter tissue contained a mixture of green fluorescent protein positive cells and predominantly green fluorescent protein negative cells.
CONCLUSIONS: Injected skeletal muscle progenitor cells incorporated into the injured sphincter complex resulted in long-term structural and functional restoration of the injured sphincter complex in this nonhuman primate model.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DMEM; Dulbecco's modified Eagle's medium; FACS; GFP; MHC; MPC; MUP; Macaca fascicularis; MyoD; PAX7; SUI; fluorescence antibody cell sorting; green fluorescent protein; maximal urethral pressure; muscle progenitor cell; myoblast determination protein; myosin heavy chain; paired box protein-7; pudendal nerve; skMPC; skeletal MPC; stem cells; stress; stress urinary incontinence; urinary bladder; urinary incontinence

Mesh:

Year:  2013        PMID: 23618586     DOI: 10.1016/j.juro.2013.04.052

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Multiple doses of stem cells maintain urethral function in a model of neuromuscular injury resulting in stress urinary incontinence.

Authors:  Kristine Janssen; Dan Li Lin; Brett Hanzlicek; Kangli Deng; Brian M Balog; Carl H van der Vaart; Margot S Damaser
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-14

Review 2.  Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency.

Authors:  Christopher James Hillary; Nadir Osman; Christopher Chapple
Journal:  World J Urol       Date:  2015-06-10       Impact factor: 4.226

3.  The dose-effect safety profile of skeletal muscle precursor cell therapy in a dog model of intrinsic urinary sphincter deficiency.

Authors:  J Koudy Williams; Delrae Eckman; Ashley Dean; Mahmoudreza Moradi; Julie Allickson; J Mark Cline; James J Yoo; Anthony Atala
Journal:  Stem Cells Transl Med       Date:  2015-01-30       Impact factor: 6.940

4.  Urethral musculature and innervation in the female rat.

Authors:  Xiaoyu Zhang; Amjad Alwaal; Guiting Lin; Huixi Li; Uwais B Zaid; Guifang Wang; Lin Wang; Lia Banie; Hongxiu Ning; Ching-Shwun Lin; Yinglu Guo; Liqun Zhou; Tom F Lue
Journal:  Neurourol Urodyn       Date:  2015-01-18       Impact factor: 2.696

Review 5.  Regenerative medicine and injection therapies in stress urinary incontinence.

Authors:  Christopher J Hillary; Sabiniano Roman; Sheila MacNeil; Wilhelm K Aicher; Arnulf Stenzl; Christopher R Chapple
Journal:  Nat Rev Urol       Date:  2020-01-23       Impact factor: 14.432

Review 6.  Large Animal Models for Investigating Cell Therapies of Stress Urinary Incontinence.

Authors:  Bastian Amend; Niklas Harland; Jasmin Knoll; Arnulf Stenzl; Wilhelm K Aicher
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

Review 7.  Prospects of stem cell treatment in benign urological diseases.

Authors:  Amjad Alwaal; Ahmed A Hussein; Ching-Shwun Lin; Tom F Lue
Journal:  Korean J Urol       Date:  2015-03-30

8.  Local versus intravenous injections of skeletal muscle precursor cells in nonhuman primates with acute or chronic intrinsic urinary sphincter deficiency.

Authors:  J Koudy Williams; Gopal Badlani; Ashley Dean; Shannon Lankford; Kimberly Poppante; Tracy Criswell; Karl-Erik Andersson
Journal:  Stem Cell Res Ther       Date:  2016-10-07       Impact factor: 6.832

9.  Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency.

Authors:  James Koudy Williams; Ashley Dean; Shannon Lankford; Tracy Criswell; Gopal Badlani; Karl-Erik Andersson
Journal:  Stem Cell Res Ther       Date:  2017-01-06       Impact factor: 6.832

10.  Small activating RNA induces myogenic differentiation of rat adipose-derived stem cells by upregulating MyoD.

Authors:  Chenghe Wang; Zhong Chen; Jia Wu; Yan Zhang; Jia Hu; Qiangqiang Ge; Weimin Yang; Hua Xu; Jihong Liu; Zhangqun Ye
Journal:  Int Braz J Urol       Date:  2015 Jul-Aug       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.